Doyle John Brendan 4
4 · COGNITION THERAPEUTICS INC · Filed Feb 20, 2024
Insider Transaction Report
Form 4
Doyle John Brendan
Chief Financial Officer
Transactions
- Award
Common Stock
2024-02-15+20,000→ 129,824 total - Award
Stock Option (Right to Buy)
2024-02-15+20,000→ 20,000 totalExercise: $1.98Exp: 2034-02-15→ Common Stock (20,000 underlying)
Footnotes (2)
- [F1]Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement.
- [F2]The option vests 25% on February 15, 2025, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service through the applicable vesting dates.